|
1
|
Lewis IJ, Nooij MA, Whelan J, Sydes MR,
Grimer R, Hogendoorn PC, Memon MA, Weeden S, Uscinska BM, van
Glabbeke M, et al: Improvement in histologic response but not
survival in osteosarcoma patients treated with intensified
chemotherapy: A randomized phase III trial of the European
osteosarcoma intergroup. J Natl Cancer Inst. 99:112–128. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Buddingh EP, Anninga JK, Versteegh MI,
Taminiau AH, Egeler RM, van Rijswijk CS, Hogendoorn PC, Lankester
AC and Gelderblom H: Prognostic factors in pulmonary metastasized
high-grade osteosarcoma. Pediatr Blood Cancer. 54:216–221.
2010.PubMed/NCBI
|
|
3
|
Kapoor A and Kumar S: Cancer stem cell: A
rogue responsible for tumor development and metastasis. Indian J
Cancer. 51:282–289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu XF, Yang WT, Xu R, Liu JT and Zheng
PS: Cervical cancer cells with positive Sox2 expression exhibit the
properties of cancer stem cells. PLoS One. 9:e870922014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu XS, Xi HQ and Chen L: Lgr5 is a
potential marker of colorectal carcinoma stem cells that correlates
with patient survival. World J Surg Oncol. 10:2442012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Toda M, Iizuka Y, Yu W, Imai T, Ikeda E,
Yoshida K, Kawase T, Kawakami Y, Okano H and Uyemura K: Expression
of the neural RNA-binding protein Musashi1 in human gliomas. Glia.
34:1–7. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sanchez-Diaz PC, Burton TL, Burns SC, Hung
JY and Penalva LO: Musashi1 modulates cell proliferation genes in
the medulloblastoma cell line Daoy. BMC Cancer. 8:2802008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fan LF, Dong WG, Jiang CQ, Xia D, Liao F
and Yu QF: Expression of putative stem cell genes Musashi-1 and
beta1-integrin in human colorectal adenomas and adenocarcinomas.
Int J Colorectal Dis. 25:17–23. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang XY, Yu H, Linnoila RI, Li L, Li D, Mo
B, Okano H, Penalva LO and Glazer RI: Musashi1 as a potential
therapeutic target and diagnostic marker for lung cancer.
Oncotarget. 4:739–750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ye F, Zhou C, Cheng Q, Shen J and Chen H:
Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are
highlyexpressed in malignant cervical epithelial cells. BMC Cancer.
8:1082008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang XY, Penalva LO, Yuan H, Linnoila RI,
Lu J, Okano H and Glazer RI: Musashi1 regulates breast tumor cell
proliferation and is a prognostic indicator of poor survival. Mol
Cancer. 9:2212010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang XY, Yin Y, Yuan H, Sakamaki T, Okano
H and Glazer RI: Musashi1 modulates mammary progenitor cell
expansion through proliferin-mediated activation of the Wnt and
Notch pathways. Mol Cell Biol. 28:3589–3599. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Muto J, Imai T, Ogawa D, Nishimoto Y,
Okada Y, Mabuchi Y, Kawase T, Iwanami A, Mischel PS, Saya H, et al:
RNA-binding protein Musashi1 modulates glioma cell growth through
the post-transcriptional regulation of Notch and PI3 kinase/Akt
signaling pathways. PLoS One. 7:e334312012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nikpour P, Baygi ME, Steinhoff C, Hader C,
Luca AC, Mowla SJ and Schulz WA: The RNA binding protein
Musashi1regulates apoptosis, gene expression and stress granule
formation in urothelial carcinoma cells. J Cell Mol Med.
15:1210–1224. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang XY, Penalva LO, Yuan H, Linnoila RI,
Lu J, Okano H and Glazer RI: Musashi1 regulates breast tumor cell
proliferation and is a prognostic indicator of poor survival. Mol
Cancer. 9:2212010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu X, Yang WT and Zheng PS: Msi1 promotes
tumor growth and cell proliferation by targeting cell cycle
checkpoint proteins p21, p27 and p53 in cervical carcinomas.
Oncotarget. 5:10870–10885. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Götte M, Greve B, Kelsch R, Müller-Uthoff
H, Weiss K, Masouleh Kharabi B, Sibrowski W, Kiesel L and Buchweitz
O: The adult stem cell marker Musashi-1 modulates endometrial
carcinoma cell cycle progression and apoptosis via Notch-1 and p21
WAF1/CIP1. Int J Cancer. 129:2042–2049. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Abdelmohsen K, Srikantan S, Kuwano Y and
Gorospe M: miR-519 reduces cell proliferation by lowering
RNA-binding protein HuR levels. Proc Natl Acad Sci USA.
105:20297–20302. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Busà R, Paronetto MP, Farini D,
Pierantozzi E, Botti F, Angelini DF, Attisani F, Vespasiani G and
Sette C: The RNA-binding protein Sam68 contributes to proliferation
and survival of human prostate cancer cells. Oncogene.
26:4372–4382. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sutherland LC, Rintala-Maki ND, White RD
and Morin CD: RNA binding motif (RBM) proteins: A novel family of
apoptosis modulators? J Cell Biochem. 94:5–24. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kaneko Y, Sakakibara S, Imai T, Suzuki A,
Nakamura Y, Sawamoto K, Ogawa Y, Toyama Y, Miyata T and Okano H:
Musashi1: An evolutionally conserved marker for CNS progenitor
cells including neural stem cells. Dev Neurosci. 22:139–153. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Okano H, Kawahara H, Toriya M, Nakao K,
Shibata S and Imai T: Function of RNA-binding protein Musashi-1 in
stem cells. Exp Cell Res. 306:349–356. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rezza A and Plateroti M: M1621 Study of
the RNA binding protein Musashi1, An intestinal epithelial stem
cell marker. Gastroenterology. 136:A–396. 2009. View Article : Google Scholar
|
|
24
|
Vo DT, Subramaniam D, Remke M, Burton TL,
Uren PJ, Gelfond JA, de Sousa Abreu R, Burns SC, Qiao M, Suresh U,
et al: The RNA-binding protein Musashi1 affects medulloblastoma
growth via a network of cancer-related genes and is an indicator of
poor prognosis. Am J Pathol. 181:1762–1772. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi C and Zhang Z: miR-761 inhibits tumor
progression by targeting MSI1 in ovarian carcinoma. Tumor Biol.
37:5437–5443. 2016. View Article : Google Scholar
|
|
26
|
Akasaka Y, Saikawa Y, Fujita K, Kubota T,
Ishikawa Y, Fujimoto A, Ishii T, Okano H and Kitajima M: Expression
of a candidate marker for progenitor cells, Musashi-1, in the
proliferative regions of human antrum and its decreased expression
in intestinal metaplasia. Histopathology. 47:348–356. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wei JG, Zhao F and Sun AJ: Effect of Msi1
siRNA on proliferation of SW-480 cell line. Chin J Clin Exp Pathol.
2012.
|
|
28
|
Wang YF, Chen NS, Chung YP, Chang LH,
Chiou YH and Chen CY: Sodium butyrate induces apoptosis and cell
cycle arrest in primary effusion lymphoma cells independently of
oxidative stress and p21 CIP1/WAF1 induction. Mol Cell Biochem.
285:51–59. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Møller MB: P27 in cell cycle control and
cancer. Leuk Lymphoma. 39:19–27. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu DF, Ferguson K, Cooper GS, Grady WM
and Willis J: p27 cell-cycle inhibitor is inversely correlated with
lymph node metastases in right-sided colon cancer. J Clin Lab Anal.
13:291–295. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Coqueret O: New roles for p21 and p27
cell-cycle inhibitors: A function for each cell compartment? Trends
in Cell Biol. 13:65–70. 2003. View Article : Google Scholar
|
